Precision Vaccinations News
Search
Inline CSS
Clinical Trials
Lab Tests
Subscribe
Trials
Labs
Subscribe
Home
Dengue
Flu
Measles
RSV
STD
Travel
Vaccines
Anthrax
Fact checked by
Robert Carlson, MD
Oct 23
3 min read
Next-Gen Anthrax Vaccine To Launch Phase 1 Study
BlueWillow Biologics BW-1010 is an intranasal anthrax vaccine candidate
Anthrax
Fact checked by
Robert Carlson, MD
Aug 1
4 min read
BARDA Exercises $261 Million Dollar Option for Innovative Anthrax Vaccine
Emergent BioSolutions AV7909 anthrax vaccine being added to the Strategic National Stockpile
Anthrax
Fact checked by
Robert Carlson, MD
Jun 29
5 min read
2nd Anthrax Case Confirmed in Texas Animals
Anthrax vaccine and medications reduce illness and mortality risks from anthrax
Anthrax
Fact checked by
Robert Carlson, MD
Jun 5
4 min read
Anthrax Vaccine Candidate NanoVax Awarded Patent
BlueWillow’s NanoVax vaccine platform employs a novel oil-in-water emulsion adjuvant that elicits both systemic and mucosal immunity
Anthrax
Fact checked by
Robert Carlson, MD
May 17
3 min read
BARDA to Purchase Anthrax Vaccine for Strategic Stockpile
Emergent Anthrax Vaccine AV7909 consists of Anthrax Vaccine Adsorbed drug substance and CPG 7909 adjuvant
Anthrax
Show more